Teva Pharmaceutical Industries Ltd (TEVJF) SEC Filings — 2024
16 SEC filings for Teva Pharmaceutical Industries Ltd (TEVJF) in 2024.
Filings
- Teva Pharma Announces Executive and Director Changes — 8-K · Nov 12, 2024
- Teva Pharmaceutical Industries Ltd SC 13G Filing — SC 13G · Nov 12, 2024
- Teva Pharma Repays Debt, Faces Bond Target Risks — 10-Q · Nov 6, 2024
- Teva Pharma Files 8-K on Operations & Financials — 8-K · Nov 6, 2024
- Teva Pharma Q2: $16M Hedge Gain, Allergan Contingent Consideration Revised — 10-Q · Jul 31, 2024
- Teva Pharma Files 8-K on Operations and Financials — 8-K · Jul 31, 2024
- Teva Pharma Signs Material Definitive Agreement — 8-K · Jun 25, 2024
- Teva Pharmaceuticals Files 8-K on Security Holder Vote — 8-K · Jun 6, 2024
- Teva Pharma Appoints New CFO, Elects Directors — 8-K · May 15, 2024
- Teva Pharmaceutical Industries Ltd. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- Teva Pharma Files 8-K with 2023 Segment Financials — 8-K · Apr 18, 2024
- Teva Pharma's 2024 Shareholder Meeting: Growth & Innovation Focus — DEF 14A · Apr 16, 2024
- Teva Pharmaceutical Industries Ltd SC 13G/A Filing — SC 13G/A · Apr 9, 2024
- Teva Pharmaceuticals Files 2023 Annual Report on Form 10-K — 10-K · Feb 12, 2024
- Phoenix Holdings Discloses 60.5M Share Stake in Teva Pharma — SC 13G · Feb 1, 2024
- TEVA Files 8-K on Operations & Financial Condition — 8-K · Jan 31, 2024